FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2738417872> ?p ?o ?g. }

• W2738417872 endingPage "89148" @default.
• W2738417872 startingPage "89142" @default.
• W2738417872 abstract "// Zhulei Sun 1, * , Juncai Liu 2, * , Hong Jing 1 , Shu-Xiao Dong 3 and Jiang Wu 1 1 Department of Pathology, Huaihe Hospital, Henan University, 8 Bao Bei Lu, GuLou Qu, Kaifeng 475000, China 2 Department of Radiotherapy, Huaihe Hospital, Henan University, Kaifeng 475000, China 3 Department of Gastrointestinal Surgery, Linyi People’s Hospital, Linyi 276001, Shandong, China * These authors contributed equally to this work Correspondence to: Jiang Wu, email: jiangwumi@hotmail.com Keywords: CHFR, methylation, biomarker, CRC, colorectal carcinoma Received: March 13, 2017      Accepted: June 24, 2017      Published: July 20, 2017 ABSTRACT The Checkpoint with Forkhead-associated and Ring finger domains ( CHFR ) is a mitotic checkpoint and tumor-suppressor gene, its loss contributes tumorigenesis of epithelial cancers including colorectal carcinoma (CRC). The diagnostic and prognostic value of CHFR promoter hypermethylation in CRC remains unclear. This study aimed to conduct a meta-analysis and literature review and investigate clinicopathological significance of CHFR promoter hypermethylation in CRC. The following online database were used: PubMed, EMBASE, and Web of Science up to March 2017. Odds Ratios (OR) and Hazard Ratios (HR) with 95% corresponding confidence intervals (CIs) were calculated. A total of seven relevant articles were available for meta-analysis which included 966 patients. The frequency of CHFR promoter hypermethylation significantly increased in CRC compared to normal colorectal mucosa tissue, pooled OR was 8.35, p < 0.00001. CHFR promoter hypermethylation was not significantly correlated to stage, OR was 1.16, p = 0.63. However, CHFR promoter hypermethylation was more frequently observed in CRC with positive lymph nodes metastasis than CRC with negative lymph nodes metastasis, OR was 0.46, p = 0.03. Additionally CHFR promoter hypermethylation was significantly related to poor overall survival in patients with CRC, HR was 0.62, p = 0.008. Based on these results, tumor CHFR promoter hypermethylation is not only a diagnostic biomarker for CRC, but also a prognostic marker. CHFR promoter hypermethylation is significantly associated with worse overall survival in patients with CRC. Our data suggested that CHFR could be a potential drug target for development of demethylation treatment for patients with CRC." @default.
• W2738417872 created "2017-07-31" @default.
• W2738417872 creator A5006677836 @default.
• W2738417872 creator A5015855316 @default.
• W2738417872 creator A5025715009 @default.
• W2738417872 creator A5034534226 @default.
• W2738417872 creator A5075864218 @default.
• W2738417872 date "2017-07-20" @default.
• W2738417872 modified "2023-09-24" @default.
• W2738417872 title "The diagnostic and prognostic value of <i>CHFR</i> hypermethylation in colorectal cancer, a meta-analysis and literature review" @default.
• W2738417872 cites W1591774929 @default.
• W2738417872 cites W1967641707 @default.
• W2738417872 cites W1971770672 @default.
• W2738417872 cites W1974773964 @default.
• W2738417872 cites W1975476791 @default.
• W2738417872 cites W1985407849 @default.
• W2738417872 cites W1989478892 @default.
• W2738417872 cites W1992159038 @default.
• W2738417872 cites W2033267973 @default.
• W2738417872 cites W2034269086 @default.
• W2738417872 cites W2035554677 @default.
• W2738417872 cites W2045229182 @default.
• W2738417872 cites W2055838552 @default.
• W2738417872 cites W2096007903 @default.
• W2738417872 cites W2103742944 @default.
• W2738417872 cites W2125435699 @default.
• W2738417872 cites W2126166557 @default.
• W2738417872 cites W2142342107 @default.
• W2738417872 cites W2144140175 @default.
• W2738417872 cites W2152070575 @default.
• W2738417872 cites W2166340158 @default.
• W2738417872 cites W2167903105 @default.
• W2738417872 cites W2169453999 @default.
• W2738417872 cites W2171535052 @default.
• W2738417872 cites W2188033081 @default.
• W2738417872 cites W2235523093 @default.
• W2738417872 cites W4238448376 @default.
• W2738417872 cites W4240237951 @default.
• W2738417872 doi "https://doi.org/10.18632/oncotarget.19408" @default.
• W2738417872 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5687676" @default.
• W2738417872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29179506" @default.
• W2738417872 hasPublicationYear "2017" @default.
• W2738417872 type Work @default.
• W2738417872 sameAs 2738417872 @default.
• W2738417872 citedByCount "13" @default.
• W2738417872 countsByYear W27384178722018 @default.
• W2738417872 countsByYear W27384178722019 @default.
• W2738417872 countsByYear W27384178722020 @default.
• W2738417872 countsByYear W27384178722021 @default.
• W2738417872 countsByYear W27384178722022 @default.
• W2738417872 countsByYear W27384178722023 @default.
• W2738417872 crossrefType "journal-article" @default.
• W2738417872 hasAuthorship W2738417872A5006677836 @default.
• W2738417872 hasAuthorship W2738417872A5015855316 @default.
• W2738417872 hasAuthorship W2738417872A5025715009 @default.
• W2738417872 hasAuthorship W2738417872A5034534226 @default.
• W2738417872 hasAuthorship W2738417872A5075864218 @default.
• W2738417872 hasBestOaLocation W27384178721 @default.
• W2738417872 hasConcept C104317684 @default.
• W2738417872 hasConcept C121608353 @default.
• W2738417872 hasConcept C126322002 @default.
• W2738417872 hasConcept C143998085 @default.
• W2738417872 hasConcept C150194340 @default.
• W2738417872 hasConcept C156957248 @default.
• W2738417872 hasConcept C190727270 @default.
• W2738417872 hasConcept C207103383 @default.
• W2738417872 hasConcept C44249647 @default.
• W2738417872 hasConcept C526805850 @default.
• W2738417872 hasConcept C55493867 @default.
• W2738417872 hasConcept C71924100 @default.
• W2738417872 hasConcept C86803240 @default.
• W2738417872 hasConcept C95190672 @default.
• W2738417872 hasConceptScore W2738417872C104317684 @default.
• W2738417872 hasConceptScore W2738417872C121608353 @default.
• W2738417872 hasConceptScore W2738417872C126322002 @default.
• W2738417872 hasConceptScore W2738417872C143998085 @default.
• W2738417872 hasConceptScore W2738417872C150194340 @default.
• W2738417872 hasConceptScore W2738417872C156957248 @default.
• W2738417872 hasConceptScore W2738417872C190727270 @default.
• W2738417872 hasConceptScore W2738417872C207103383 @default.
• W2738417872 hasConceptScore W2738417872C44249647 @default.
• W2738417872 hasConceptScore W2738417872C526805850 @default.
• W2738417872 hasConceptScore W2738417872C55493867 @default.
• W2738417872 hasConceptScore W2738417872C71924100 @default.
• W2738417872 hasConceptScore W2738417872C86803240 @default.
• W2738417872 hasConceptScore W2738417872C95190672 @default.
• W2738417872 hasIssue "51" @default.
• W2738417872 hasLocation W27384178721 @default.
• W2738417872 hasLocation W27384178722 @default.
• W2738417872 hasLocation W27384178723 @default.
• W2738417872 hasLocation W27384178724 @default.
• W2738417872 hasOpenAccess W2738417872 @default.
• W2738417872 hasPrimaryLocation W27384178721 @default.
• W2738417872 hasRelatedWork W1900595920 @default.
• W2738417872 hasRelatedWork W2047252483 @default.
• W2738417872 hasRelatedWork W2065895388 @default.
• W2738417872 hasRelatedWork W2286371484 @default.
• W2738417872 hasRelatedWork W2318119155 @default.

• next